Author:
Kraus M,Bader J,Overkleeft H,Driessen C
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Wlodawer A, Vondrasek J . Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. Annu Rev Biophys Biomol Struct 1998; 27: 249–284.
2. Chow WA, Jiang C, Guan M . Anti-HIV drugs for cancer therapeutics: back to the future? Lancet Oncol 2009; 10: 61–71.
3. Esposito V, Palescandolo E, Spugnini EP, Montesarchio V, De LA, Cardillo I et al. Evaluation of antitumoral properties of the protease inhibitor indinavir in a murine model of hepatocarcinoma. Clin Cancer Res 2006; 12: 2634–2639.
4. Sgadari C, Barillari G, Toschi E, Carlei D, Bacigalupo I, Baccarini S et al. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat Med 2002; 8: 225–232.
5. Gaedicke S, Firat-Geier E, Constantiniu O, Lucchiari-Hartz M, Freudenberg M, Galanos C et al. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis. Cancer Res 2002; 62: 6901–6908.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献